Leigha Senter

10.3k citations

75 papers · 2.3k · h-index 23

Impact in

Pathology and Forensic Medicine top 1%
- Genetic factors in colorectal cancer
Cancer Research top 5%
- Cancer Genomics and Diagnostics

Papers in

Genetics 38
- BRCA gene mutations in cancer 37
Pathology and Forensic Medicine 17
- Genetic factors in colorectal cancer 15

Co-authors: Albert de la Chapelle (12 shared papers)Henry T. Lynch (17 shared papers)Steven A. Narod (22 shared papers)Jan Lubiński (20 shared papers)Nadine Tung (18 shared papers)Heather Hampel (7 shared papers)Pål Møller (12 shared papers)Mark Clendenning (7 shared papers)
Journals: Gynecologic Oncology (9 papers)Breast Cancer Research and Treatment (6 papers)Clinical Genetics (4 papers)British Journal of Cancer (3 papers)Familial Cancer (3 papers)
Partner nations: United States Canada Poland

In The Last Decade

Leigha Senter

71 papers receiving 2.3k citations

Peers

Countries citing papers authored by Leigha Senter

Since Specialization

Citations

This map shows the geographic impact of Leigha Senter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leigha Senter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leigha Senter more than expected).

Fields of papers citing papers by Leigha Senter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leigha Senter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leigha Senter. The network helps show where Leigha Senter may publish in the future.

Co-authors

The 25 scholars most cited alongside Leigha Senter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Leigha Senter Line = papers co-authored together Leigha Senter links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The Clinical Phenotype of Lynch Syndrome Due to Germ-Line PMS2 Mutations Gastroenterology ·Leigha Senter, Mark Clendenning, Kaisa Sotamaa, Heather Hampel, Jane Green, John D. Potter, Annika Lindblom, Kristina Lagerstedt‐Robinson, Stephen N. Thibodeau, Noralane M. Lindor, Joanne Young, Ingrid Winship, James G. Dowty, Darren M. White, John L. Hopper, Laura Baglietto, Mark A. Jenkins, Albert de la Chapelle	2008	380
2	The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers British Journal of Cancer ·(unknown), Javaid Iqbal, Alejandra Ragone, Jan Lubiński, Henry T. Lynch, Pål Møller, P Ghadirian, William D. Foulkes, Susan Randall Armel, Andrea Eisen, Susan L. Neuhausen, Leigha Senter, Christian F. Singer, Peter Ainsworth, Charmaine Kim‐Sing, Nadine Tung, Eitan Friedman, M Llacuachaqui, (unknown), Steven A. Narod	2012	182
3	International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation British Journal of Cancer ·Kelly Metcalfe, Andrea Eisen, Leigha Senter, Susan Randall Armel, Louise Bordeleau, Wendy S. Meschino, Tuya Pal, Henry T. Lynch, Nadine Tung, Ava Kwong, Peter Ainsworth, Beth Y. Karlan, Pål Møller, Charis Eng, Jeffrey N. Weitzel, Ping Sun, Jan Lubiński, Steven A. Narod	2019	109
4	Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers JAMA Oncology ·Joanne Kotsopoulos, Jacek Gronwald, Beth Y. Karlan, Tomasz Huzarski, Nadine Tung, Pål Møller, Susan Randall Armel, Henry T. Lynch, Leigha Senter, Andrea Eisen, Christian F. Singer, William D. Foulkes, Michelle Jacobson, Ping Sun, Jan Lubiński, Steven A. Narod	2018	106
5	Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study British Journal of Cancer ·(unknown), Catherine M. Phelan, Javaid Iqbal, Henry T. Lynch, Jan Lubiński, Jacek Gronwald, Pål Møller, P Ghadirian, William D. Foulkes, Susan Randall Armel, Andrea Eisen, Susan L. Neuhausen, Leigha Senter, C Singer, Peter Ainsworth, Charmaine Kim‐Sing, Nadine Tung, M Llacuachaqui, Ganna Chornokur, (unknown), Steven A. Narod	2013	103
6	Identification of Individuals at Risk for Lynch Syndrome Using Targeted Evaluations and Genetic Testing: National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Colorectal Cancer Joint Practice Guideline Journal of Genetic Counseling ·Scott M. Weissman, Randall W. Burt, James M. Church, Steve Erdman, Heather Hampel, Spring Holter, Kory Jasperson, Matt F. Kalady, Joy Larsen Haidle, Henry T. Lynch, Selvi Palaniappan, Paul E. Wise, Leigha Senter	2011	97
7	BRCA mutation in ovarian cancer: testing, implications and treatment considerations Therapeutic Advances in Medical Oncology ·Robert Neff, Leigha Senter, Ritu Salani	2017	92
8	Long-range PCR facilitates the identification ofPMS2-specific mutations Human Mutation ·Mark Clendenning, Heather Hampel, Jennifer LaJeunesse, Annika Lindblom, Jan Lockman, Mef Nilbert, Leigha Senter, Kaisa Sotamaa, Albert de la Chapelle	2006	78
9	The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: An international prospective cohort study Gynecologic Oncology ·Yakir Segev, Javaid Iqbal, Jan Lubiński, Jacek Gronwald, Henry T. Lynch, Pål Møller, Parviz Ghadirian, Barry P. Rosen, Nadine Tung, Charmaine Kim‐Sing, William D. Foulkes, Susan L. Neuhausen, Leigha Senter, Christian F. Singer, Beth Y. Karlan, Sun Ping, Steven A. Narod	2013	76
10	Implementing screening for Lynch syndrome among patients with newly diagnosed colorectal cancer: summary of a public health/clinical collaborative meeting Genetics in Medicine ·Cecelia Bellcross, Sara Bedrosian, Elvan Daniels, Debra Duquette, Heather Hampel, Kory Jasperson, Djenaba Joseph, Celia I. Kaye, Ira M. Lubin, Laurence J. Meyer, Michele Reyes, Maren T. Scheuner, Sheri D. Schully, Leigha Senter, Sherri L. Stewart, Jeanette St. Pierre, Judith A. Westman, Paul E. Wise, Vincent W. Yang, Muin J. Khoury	2012	70
11	Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation Gynecologic Oncology ·Joanne Kotsopoulos, Jacek Gronwald, Beth Y. Karlan, Barry P. Rosen, Tomasz Huzarski, Pål Møller, Henry T. Lynch, Christian F. Singer, Leigha Senter, Susan L. Neuhausen, Nadine Tung, Andrea Eisen, William D. Foulkes, Peter Ainsworth, Ping Sun, Jan Lubiński, Steven A. Narod	2018	67
12	Consumer awareness and attitudes about insurance discrimination post enactment of the Genetic Information Nondiscrimination Act Familial Cancer ·Dawn C. Allain, Sue Friedman, Leigha Senter	2012	53
13	Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case–control study Breast Cancer Research and Treatment ·Joanne Kotsopoulos, Tomasz Huzarski, Jacek Gronwald, Pål Møller, Henry T. Lynch, Susan L. Neuhausen, Leigha Senter, Rochelle Demsky, William D. Foulkes, Charis Eng, Beth Y. Karlan, Nadine Tung, Christian F. Singer, Ping Sun, Jan Lubiński, Steven A. Narod	2016	51
14	Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers International Journal of Cancer ·Joanne Kotsopoulos, Jan Lubiński, Jacek Gronwald, Cezary Cybulski, Rochelle Demsky, Susan L. Neuhausen, Charmaine Kim‐Sing, Nadine Tung, Susan Friedman, Leigha Senter, Jeffrey N. Weitzel, Beth Y. Karlan, Pål Møller, Ping Sun, Steven A. Narod	2014	48
15	Genome-Wide Expression Screening Discloses Long Noncoding RNAs Involved in Thyroid Carcinogenesis The Journal of Clinical Endocrinology & Metabolism ·Sandya Liyanarachchi, Wei Li, Pearlly S. Yan, Ralf Bundschuh, Pamela Brock, Leigha Senter, Matthew D. Ringel, Albert de la Chapelle, Huiling He	2016	48
16	Characterization of a New Chronic Lymphocytic Leukemia Cell Line for Mechanistic In Vitro and In Vivo Studies Relevant to Disease PLoS ONE ·Erin Hertlein, Kyle A. Beckwith, Gerard Lozanski, Timothy L. Chen, William H. Towns, Amy J. Johnson, Amy Lehman, Amy S. Ruppert, Brad Bolon, Leslie A. Andritsos, Arletta Lozanski, Laura Z. Rassenti, Weiqiang Zhao, Tiina M. Järvinen, Leigha Senter, Carlo M. Croce, David E. Symer, Albert de la Chapelle, Nyla A. Heerema, John C. Byrd	2013	47
17	Genetic consultation embedded in a gynecologic oncology clinic improves compliance with guideline-based care Gynecologic Oncology ·Leigha Senter, David M. O’Malley, Floor Backes, Larry J. Copeland, Jeffery M. Fowler, Ritu Salani, David E. Cohn	2017	46
18	A frame-shift mutation of PMS2 is a widespread cause of Lynch syndrome Journal of Medical Genetics ·Mark Clendenning, Leigha Senter, Heather Hampel, Kristina Lagerstedt‐Robinson, Shuxin Sun, Daniel D. Buchanan, Michael D. Walsh, Mef Nilbert, J. Green, John D. Potter, Annika Lindblom, Albert de la Chapelle	2008	39
19	Thyroglobulin Liquid Chromatography–Tandem Mass Spectrometry Has a Low Sensitivity for Detecting Structural Disease in Patients with Antithyroglobulin Antibodies Thyroid ·Umal Azmat, Kyle Porter, Leigha Senter, Matthew D. Ringel, Fadi Nabhan	2016	37
20	Somatic MED12 mutations are associated with poor prognosis markers in chronic lymphocytic leukemia Oncotarget ·Kati Kämpjärvi, Tiina M. Järvinen, Tuomas Heikkinen, Amy S. Ruppert, Leigha Senter, Kevin W. Hoag, Olli Dufva, Mika Kontro, Laura Z. Rassenti, Erin Hertlein, Thomas J. Kipps, Kimmo Porkka, John C. Byrd, Albert de la Chapelle, Pia Vahteristo	2014	35

About Leigha Senter

Leigha Senter is a scholar working on Genetics, Pathology and Forensic Medicine, Oncology, Cancer Research and Molecular Biology, having authored 75 papers that have together received 2.3k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (37 papers), Genetic factors in colorectal cancer (15 papers), Cancer Genomics and Diagnostics (10 papers), Ovarian cancer diagnosis and treatment (10 papers), Thyroid Cancer Diagnosis and Treatment (7 papers), Colorectal Cancer Screening and Detection (6 papers), PARP inhibition in cancer therapy (5 papers) and DNA Repair Mechanisms (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (838 citations), Cancer Research (519 citations), Reproductive Medicine (271 citations), Genetics (850 citations) and Oncology (672 citations). Leigha Senter has collaborated with scholars based in United States, Canada and Poland. Frequent co-authors include Albert de la Chapelle, Henry T. Lynch, Steven A. Narod, Jan Lubiński, Nadine Tung, Heather Hampel, Pål Møller, Mark Clendenning, Ritu Salani and William D. Foulkes. Their work appears in journals such as Gynecologic Oncology, Breast Cancer Research and Treatment, Clinical Genetics, British Journal of Cancer and Familial Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Leigha Senter

Impact in

Papers in i

In The Last Decade

Leigha Senter

Peers

Countries citing papers authored by Leigha Senter

Fields of papers citing papers by Leigha Senter

All Works

About Leigha Senter

Explore authors with similar magnitude of impact

Papers in